Responsiveness of different dynamic contrast-enhanced magnetic resonance imaging approaches: a post-hoc analysis of a randomized controlled trial of certolizumab pegol in rheumatoid arthritis.

Conclusions: Certain DCE-MRI parameters detected decreased inflammation during CZP treatment in RA patients. Using specific criteria for ROIs, as in the Detailed and Single-joint methods, decreased the statistical power and could not show any changes over time. PMID: 31524046 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31524046?dopt=Abstract

Source: Scandinavian Journal of Rheumatology - September 15, 2019 Category: Rheumatology Authors: Axelsen MB, Boesen M, Bliddal H, Jacobsson L, Hansen MS, Østergaard M Tags: Scand J Rheumatol Source Type: research